Brian O Mahony/X
Jun 24, 2025, 22:08
Rewriting Your DNA in Childhood: Because Why Wait to Cure Hemophilia? | ISTH 2025 Breakthrough
Ben Samelson-Jones, Assistant Professor of Pediatrics at University of Pennsylvania School of Medicine, posted on X:
”Sustained and stable FIX levels have now been repeatedly been observed across multiple #genetherapy clinical trials for Hemophila B. Will extend the red line tomorrow at Clinical Gene Therapy session at ISTH2025.”
Reposting from Brian O Mahony, CEO of the Irish Haemophilia Society and former President of both the WFH and EHC, sharing bold new advances in haemophilia management presented at ISTH 2025 via X:
”FIX expression and durability compared between clinical trials. Malec, ISTH2025.”
Gene Editing: Welcome to a New World!
A shot and you are done with Hemophilia B?
Don’t miss the new updates with Hemostasis Today.
-
May 24, 2026, 17:48Flora Peyvandi: Crucial Role of Placental ADAMTS13 in Perinatal Survival
-
May 24, 2026, 17:13Mahtab Mashayekhi: The Evolving Role of Red Blood Cell Exchange in the Management of SCD
-
May 24, 2026, 17:12Silvina Graña: Helping Families Better Understand Hemophilia and Daily Life With Bleeding Disorders
-
May 24, 2026, 17:11Miikka Vikkula: Key Insights from the ISSVA 2026 World Congress
-
May 24, 2026, 17:10Mathieu Jackson: Proud to Be Present at This Historic Moment for the Global Bleeding Disorders Community
-
May 24, 2026, 17:09Ramina Fazeli: Highlighting the Emerging Role of Neutrophil Extracellular Traps in Ovarian Cancer
-
May 24, 2026, 16:12William Wallace: Normal B12 Levels May Still Cause Brain Damage and Cognitive Decline
-
May 24, 2026, 15:54Marc Carrier: Ottawa Race Weekend Raised Over 7,000 USD for Thrombosis Canada
-
May 24, 2026, 15:44Janak Sadhu: Building a Stroke-Free Mehsana Through Community Awareness and Healthcare Collaboration